Your browser doesn't support javascript.
loading
Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: A prospective surveillance study.
Seibold, Max A; Moore, Camille M; Everman, Jamie L; Williams, Blake J M; Nolin, James D; Fairbanks-Mahnke, Ana; Plender, Elizabeth G; Patel, Bhavika B; Arbes, Samuel J; Bacharier, Leonard B; Bendixsen, Casper G; Calatroni, Agustin; Camargo, Carlos A; Dupont, William D; Furuta, Glenn T; Gebretsadik, Tebeb; Gruchalla, Rebecca S; Gupta, Ruchi S; Khurana Hershey, Gurjit K; Murrison, Liza Bronner; Jackson, Daniel J; Johnson, Christine C; Kattan, Meyer; Liu, Andrew H; Lussier, Stephanie J; O'Connor, George T; Rivera-Spoljaric, Katherine; Phipatanakul, Wanda; Rothenberg, Marc E; Seroogy, Christine M; Teach, Stephen J; Zoratti, Edward M; Togias, Alkis; Fulkerson, Patricia C; Hartert, Tina V.
Affiliation
  • Seibold MA; Center for Genes, Environment, and Health, National Jewish Health, Denver, Colo; Department of Pediatrics, National Jewish Health, Denver, Colo; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine, Aurora, Colo. Electronic address: seiboldm@njhealth.o
  • Moore CM; Center for Genes, Environment, and Health, National Jewish Health, Denver, Colo; Department of Biomedical Research, National Jewish Health, Denver, Colo; Department of Biostatistics and Informatics, University of Colorado, Denver, Colo.
  • Everman JL; Center for Genes, Environment, and Health, National Jewish Health, Denver, Colo.
  • Williams BJM; Center for Genes, Environment, and Health, National Jewish Health, Denver, Colo.
  • Nolin JD; Center for Genes, Environment, and Health, National Jewish Health, Denver, Colo.
  • Fairbanks-Mahnke A; Center for Genes, Environment, and Health, National Jewish Health, Denver, Colo.
  • Plender EG; Center for Genes, Environment, and Health, National Jewish Health, Denver, Colo.
  • Patel BB; Center for Genes, Environment, and Health, National Jewish Health, Denver, Colo.
  • Arbes SJ; Rho, Inc, Chapel Hill, NC.
  • Bacharier LB; Monroe Carell Jr Children's Hospital at Vanderbilt University Medical Center, Nashville, Tenn.
  • Bendixsen CG; Marshfield Clinic, Marshfield, Wisc.
  • Calatroni A; Monroe Carell Jr Children's Hospital at Vanderbilt University Medical Center, Nashville, Tenn.
  • Camargo CA; Department of Emergency Medicine, Massachusetts General Hospital, Boston, Mass.
  • Dupont WD; Vanderbilt University Medical Center, Nashville, Tenn.
  • Furuta GT; Digestive Health Institute, Children's Hospital Colorado and Section of Pediatric Gastroenterology, Hepatology and Nutrition, Gastrointestinal Eosinophilic Diseases Program, University of Colorado School of Medicine, Aurora, Colo.
  • Gebretsadik T; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tenn.
  • Gruchalla RS; University of Texas Southwestern Medical Center, Dallas, Tex.
  • Gupta RS; Ann and Robert H. Lurie Hospital of Chicago and Northwestern University Feinberg School of Medicine, Chicago, Ill.
  • Khurana Hershey GK; Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Murrison LB; Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Jackson DJ; University of Wisconsin School of Medicine and Public Health, Madison, Wisc.
  • Johnson CC; Henry Ford Health System, Detroit, Mich.
  • Kattan M; Columbia University Medical Center, New York, NY.
  • Liu AH; Digestive Health Institute, Children's Hospital Colorado and Section of Pediatric Gastroenterology, Hepatology and Nutrition, Gastrointestinal Eosinophilic Diseases Program, University of Colorado School of Medicine, Aurora, Colo; University of Colorado School of Medicine, Aurora, Colo.
  • Lussier SJ; Rho, Inc, Chapel Hill, NC.
  • O'Connor GT; Department of Medicine, Boston University School of Medicine, Boston, Mass.
  • Rivera-Spoljaric K; the Washington University School of Medicine, St Louis, Mo.
  • Phipatanakul W; Boston Children's Hospital, Harvard Medical School, Boston, Mass.
  • Rothenberg ME; Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio.
  • Seroogy CM; University of Wisconsin School of Medicine and Public Health, Madison, Wisc.
  • Teach SJ; Children's National Hospital, Washington, DC.
  • Zoratti EM; Henry Ford Health System, Detroit, Mich.
  • Togias A; National Institute of Allergy and Infectious Diseases, Rockville, Md.
  • Fulkerson PC; National Institute of Allergy and Infectious Diseases, Rockville, Md.
  • Hartert TV; Monroe Carell Jr Children's Hospital at Vanderbilt University Medical Center, Nashville, Tenn; Vanderbilt University Medical Center, Nashville, Tenn.
J Allergy Clin Immunol ; 150(2): 302-311, 2022 08.
Article in En | MEDLINE | ID: mdl-35660376
ABSTRACT

BACKGROUND:

Whether children and people with asthma and allergic diseases are at increased risk for severe acute respiratory syndrome virus 2 (SARS-CoV-2) infection is unknown.

OBJECTIVE:

Our aims were to determine the incidence of SARS-CoV-2 infection in households with children and to also determine whether self-reported asthma and/or other allergic diseases are associated with infection and household transmission.

METHODS:

For 6 months, biweekly nasal swabs and weekly surveys were conducted within 1394 households (N = 4142 participants) to identify incident SARS-CoV-2 infections from May 2020 to February 2021, which was the pandemic period largely before a vaccine and before the emergence of SARS-CoV-2 variants. Participant and household infection and household transmission probabilities were calculated by using time-to-event analyses, and factors associated with infection and transmission risk were determined by using regression analyses.

RESULTS:

In all, 147 households (261 participants) tested positive for SARS-CoV-2. The household SARS-CoV-2 infection probability was 25.8%; the participant infection probability was similar for children (14.0% [95% CI = 8.0%-19.6%]), teenagers (12.1% [95% CI = 8.2%-15.9%]), and adults (14.0% [95% CI = 9.5%-18.4%]). Infections were symptomatic in 24.5% of children, 41.2% of teenagers, and 62.5% of adults. Self-reported doctor-diagnosed asthma was not a risk factor for infection (adjusted hazard ratio [aHR] = 1.04 [95% CI = 0.73-1.46]), nor was upper respiratory allergy or eczema. Self-reported doctor-diagnosed food allergy was associated with lower infection risk (aHR = 0.50 [95% CI = 0.32-0.81]); higher body mass index was associated with increased infection risk (aHR per 10-point increase = 1.09 [95% CI = 1.03-1.15]). The household secondary attack rate was 57.7%. Asthma was not associated with household transmission, but transmission was lower in households with food allergy (adjusted odds ratio = 0.43 [95% CI = 0.19-0.96]; P = .04).

CONCLUSION:

Asthma does not increase the risk of SARS-CoV-2 infection. Food allergy is associated with lower infection risk, whereas body mass index is associated with increased infection risk. Understanding how these factors modify infection risk may offer new avenues for preventing infection.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / COVID-19 / Hypersensitivity Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adolescent / Adult / Child / Humans Language: En Journal: J Allergy Clin Immunol Year: 2022 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / COVID-19 / Hypersensitivity Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adolescent / Adult / Child / Humans Language: En Journal: J Allergy Clin Immunol Year: 2022 Type: Article